Viewing Study NCT05170568


Ignite Creation Date: 2025-12-24 @ 5:44 PM
Ignite Modification Date: 2026-01-27 @ 7:40 AM
Study NCT ID: NCT05170568
Status: UNKNOWN
Last Update Posted: 2022-11-01
First Post: 2021-12-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: PA3-17 Injection Treatment of Adult Patients With CD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies
Sponsor: PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None CD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies View
Keywords: